Clinical Evidence: GLP-1 Safety and Effectiveness in Adolescents Recent pediatric trials have demonstrated meaningful weight loss in teenagers using GLP-1 medications, with many achieving 1015% body weight reduction over 612 months
If you notice particles, cloudiness, or discoloration, do not use that vial and contact the pharmacy for guidance
The Fourth Circuit reversed, emphasizing that exposure to a toxic substance and the need for ongoing diagnostic testing constitute present, concrete harms
POSTULATING THE ROLE OF ANDROGEN METABOLISM IN INTRACRANIAL HYPERTENSION Polycystic ovary syndrome (PCOS) and IIH share many overlapping clinical features
Prepared for the Center for Food Safety and Applied Nutrition, Food and Drug Administration, Department of Health and Human Services, Washington, DC